Coyne Terrance P.'s Form 4 filing
Royalty Pharma plc (RPRX) · filed Dec 3, 2025
- Accession no.
- 0001814876-25-000009
- Filed
- Dec 3, 2025
- Trade date
- Dec 1, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $2.77M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coyne Terrance P.CIK 0001814876 | Officer (EVP & CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Class A Ordinary Shares | SSaleDisposed | −65,832 | $39.87 | −$2,624,721.84 | 592,492 | Indirect | |
| Dec 1, 2025 | Class A Ordinary Shares | SSaleDisposed | −3,750 | $39.87 | −$149,512.5 | 47,260 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
In addition to the holdings of Class A Ordinary Shares disclosed above, the Reporting Person and family vehicles controlled by the Reporting Person hold limited partnership interests in RPI US Partners 2019, LP that are exchangeable into 6,448,180 Class A Ordinary Shares. The Reporting Person also holds 1,807,277 Class E Ordinary Shares of Royalty Pharma Holdings Ltd, certain of which are subject to vesting conditions and may, upon vesting, be converted into an equivalent number of Class A Ordinary Shares.